Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2025-12-26 @ 2:08 AM
Study NCT ID:
NCT05471505
Status:
COMPLETED
Last Update Posted:
2024-07-11
First Post:
2022-06-28
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Safety and Effectiveness of Apixaban Compared to Warfarin in Patients With Non-valvular Atrial Fibrillation (a Type of Irregular Heart Rhythm) at Higher Chance of Bleeding
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-25
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-27
Completion Date Type:
ACTUAL
First Submit Date:
2022-06-28
First Submit QC Date:
None
Study First Post Date:
2022-07-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-09-21
Results First Submit QC Date:
None
Results First Post Date:
2024-07-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-17
Last Update Post Date:
2024-07-11
Last Update Post Date Type:
ACTUAL